Compare · MTEX vs RGC
MTEX vs RGC
Side-by-side comparison of Mannatech Incorporated (MTEX) and Regencell Bioscience Holdings Limited (RGC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MTEX and RGC operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- RGC is the larger of the two at $2.77B, about 175.1x MTEX ($15.8M).
- Over the past year, MTEX is down 12.6% and RGC is down 61.5% - MTEX leads by 48.9 points.
- MTEX has hit the wire 2 times in the past 4 weeks while RGC has been quiet.
PerformanceMTEX-12.61%RGC-61.50%
2025-09-16+0.00%2026-09-15
- Company
- Mannatech Incorporated
- Regencell Bioscience Holdings Limited
- Price
- $8.11+0.37%
- $5.55-1.16%
- Market cap
- $15.8M
- $2.77B
- 1M return
- +66.53%
- +1.65%
- 1Y return
- -12.61%
- -61.50%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- News (4w)
- 2
- 0
- Recent ratings
- 0
- 0
MTEX
Mannatech Incorporated
Mannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management products. The company primarily sells its products directly, as well as through network marketing channels and a website. Mannatech, Incorporated was founded in 1993 and is headquartered in Flower Mound, Texas.
Latest MTEX
- Mannatech Incorporated filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Mannatech Announces Retirement of J. Stanley Fredrick from the Board and Appointment of Robert Toth as Chairman of the Board
- Mannatech Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SEC Form 10-Q filed by Mannatech Incorporated
- Mannatech Reports Financial Results for Second Quarter 2026
- SEC Form 4 filed by Chief Financial Officer Haider Yasir
- SEC Form 3 filed by new insider Haider Yasir
- Mannatech Incorporated filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Mannatech Announces Appointment of Yasir Haider as Chief Financial Officer
- SEC Form 4 filed by Director Toth Robert
Latest RGC
- SEC Form 4 filed by Director Lo William Wing Yan Dr
- SEC Form 4 filed by Director Hui Evana Yee Wah
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 424B5 filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited